Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
24 studies found for:    Open Studies | "Sweat"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Sweat"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair
Condition: Sweat Gland Diseases
Intervention: Biological: UCB Mesenchymal Stem Cells treatment
2 Not yet recruiting Evaluation of the Sensitivity of a Transdermal Device to Monitor the Sweat Alcohol Concentration
Condition: The Sweat Alcohol Concentration
Interventions: Other: oral dose of alcohol;   Device: alcotest;   Biological: blood samples;   Device: Transdermal monitor
3 Recruiting Investigating the Stability, Variability and Mechanism of Incorporation of Lipid Mediators Into Eccrine Sweat
Condition: Stability & Variability of Lipid-derived Molecules in Sweat
Interventions: Drug: Ibuprofen;   Other: Physiological induction of sweating;   Drug: Pilocarpine
4 Recruiting Proteomic Analysis of Sweat in Cutaneous Conditions
Condition: Application Site Perspiration
Intervention: Device: Skin Patch
5 Not yet recruiting A Multi-Center Study of the CF Quantum® Sweat Test System
Condition: Cystic Fibrosis
Intervention: Device: Iontophoresis sweat test
6 Not yet recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Conditions: Adenoid Cystic Carcinoma;   Adnexal Carcinoma;   Apocrine Carcinoma;   Eccrine Porocarcinoma;   Extraocular Cutaneous Sebaceous Carcinoma;   Hidradenocarcinoma;   Keratoacanthoma;   Malignant Sweat Gland Neoplasm;   Merkel Cell Carcinoma;   Microcystic Adnexal Carcinoma;   NK-Cell Lymphoma, Unclassifiable;   Non-Melanomatous Lesion;   Paget Disease;   Papillary Adenocarcinoma;   Primary Cutaneous Mucinous Carcinoma;   Refractory Anaplastic Large Cell Lymphoma;   Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma;   Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma;   Refractory Mycosis Fungoides;   Refractory T-Cell Non-Hodgkin Lymphoma;   Sezary Syndrome;   Signet Ring Cell Carcinoma;   Skin Basal Cell Carcinoma;   Skin Basosquamous Cell Carcinoma;   Skin Squamous Cell Carcinoma;   Spiradenocarcinoma;   Squamous Cell Carcinoma of Unknown Primary Origin;   Stage III Skin Cancer;   Stage IV Skin Cancer;   Sweat Gland Carcinoma;   Trichilemmocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Biological: Talimogene Laherparepvec
7 Recruiting Management of Palmar Hyperhidrosis With Hydrogel-based Iontophoresis
Conditions: Hyperhidrosis;   Hyperhidrosis Palmaris et Plantaris
Intervention: Device: Hydrogel electrode-based iontophoresis
8 Recruiting Miradry Treatment for Focal Axillary Hyperhidrosis
Condition: Axillary Hyperhidrosis
Intervention: Device: MiraDry ®
9 Recruiting Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis
Condition: Hyperhidrosis
Interventions: Drug: Botox (onabotulinumtoxinA);   Drug: NeuroBloc/Myobloc (rimabotulinumtoxinB);   Drug: NaCl (placebo)
10 Not yet recruiting Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
Conditions: Anemia;   Fatigue;   Fever;   Lymphadenopathy;   Lymphocytosis;   Night Sweats;   Recurrent Chronic Lymphocytic Leukemia;   Recurrent Plasma Cell Myeloma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Plasma Cell Myeloma;   Splenomegaly;   Thrombocytopenia;   Weight Loss
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Metformin Hydrochloride;   Other: Pharmacological Study;   Drug: Ritonavir
11 Recruiting Effects of Sildenafil on CFTR-dependent Ion Transport Activity
Condition: Cystic Fibrosis
Interventions: Drug: Sildenafil;   Drug: Placebo
12 Recruiting Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Intervention: Drug: Adalimumab
13 Recruiting Group Psychotherapy for Patients With Hidradenitis Suppurativa: Effects in Quality of Life
Condition: Hidradenitis
Intervention: Behavioral: psychotherapy
14 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of Illness
Condition: Hidradenitis Suppurativa (HS)
Intervention:
15 Recruiting Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study)
Condition: Hidradenitis Suppurativa
Interventions: Drug: Adalimumab;   Drug: Placebo
16 Recruiting Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting
Condition: Hidradenitis Suppurativa
Intervention:
17 Recruiting A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.
Condition: Hidradenitis Suppurativa
Interventions: Drug: Triamcinolone Acetonide 10mg/mL;   Drug: Triamcinolone Acetonide 40mg/mL;   Drug: Normal Saline
18 Recruiting Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) Patients
Condition: Hidradenitis Suppurativa
Intervention: Biological: Adalimumab
19 Recruiting Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Intervention: Drug: Apremilast
20 Not yet recruiting Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Interventions: Drug: 23.4% Hypertonic saline;   Drug: Saline

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.